XML 49 R21.htm IDEA: XBRL DOCUMENT
v3.25.2

FINANCIAL INSTRUMENTS | 12 Months Ended
--- | ---
Mar. 31, 2025
Financial Instruments [Abstract] |
FINANCIAL INSTRUMENTS | FINANCIAL INSTRUMENTS The Company’s financial instruments are exposed to certain financial risks, which include currency risk, credit risk, liquidity risk and interest rate risk. The Company has classified its financial instruments as follows:
As at | March 31, 2025 | March 31, 2024
| $ | $
Financial assets, measured at fair value: |  |
Cash | 135,022 |  | 208,992 |
Financial assets, measured at amortized cost: |  |
Accounts receivable | 706 |  | 42 |
Financial liabilities, measured at amortized cost: |  |
Accounts payable and accrued liabilities | 21,418 |  | 9,805 |
Lease liabilities | — |  | 291 |
The carrying value of the Company’s financial instruments approximate their fair value. Fair value hierarchy of financial instruments The Company has categorized its financial instruments that are carried at fair value, based on the priority of the inputs to the valuation techniques used to measure fair value, into a three-level fair value hierarchy as follows: Level 1: Fair value is based on unadjusted quoted prices for identical assets or liabilities in an active market. The types of assets and liabilities classified as Level 1 generally included cash. Level 2: Fair value is based on quoted prices for similar assets or liabilities in active markets, valuation that is based on significant observable inputs, or inputs that are derived principally from or corroborated with observable market data through correlation or other means. Currently, the Company has no financial instruments that would be classified as Level 2. Level 3: Fair value is based on valuation techniques that require one or more significant inputs that are not based on observable market inputs. These unobservable inputs reflect the Company’s assumptions about the assumptions market participants would use in pricing the asset or liability. Currently, the Company has no financial instruments that would be classified as Level 3. There were no transfers between levels of the fair value hierarchy for the year ended March 31, 2025. Financial risk management Credit risk Credit risk is the risk that one party to a financial instrument will cause a financial loss for the other party by failing to discharge an obligation. The Company’s cash is exposed to credit risk. The Company reduces its credit risk on cash by placing these instruments with institutions of high creditworthiness. As at March 31, 2025 the Company’s maximum exposure to credit risk is the carrying value of its financial assets. Liquidity risk Liquidity risk is the risk that an entity will encounter difficulty in raising funds to meet commitments associated with financial instruments. The Company manages liquidity by maintaining adequate cash balances to meet liabilities as they become due. As at March 31, 2025, the Company had cash of $135,022 (March 31, 2024 - $208,992) in order to meet current liabilities. Current liabilities include accounts payable and accrued liabilities of $21,418 (March 31, 2024 - $9,805) and lease liabilities of $nil (March 31, 2024 - $291). All amounts are due within the next 12 months. Market risk The significant market risks to which the Company is exposed are interest rate risk and currency risk. Interest rate risk Interest rate risk is the risk that the fair value or the future cash flows of a financial instrument will fluctuate because of changes in market interest rates. In seeking to minimize the risks from interest rate fluctuations, the Company manages exposure through its normal operating and financing activities. Assuming that all other variables remain constant, as at March 31, 2025, a 1% decline on the interest rate generated on cash would have resulted in a reduction of interest income of $1,145 over a one-year period. Currency risk The Company is exposed to currency risk to the extent that monetary operational expenses are denominated in both CAD and USD while the functional currency of CAD is used for reporting. The Company has not entered into any foreign currency contracts to mitigate this risk. At March 31, 2025 the Company had the following balances in monetary assets and monetary liabilities which are subject to fluctuation against CAD:
Denominated in: | US$ | GBP | EUR
Cash | 92,416 |  | 76 |  | 676 |
Accounts receivable | 353 |  | — |  | — |
Accounts payable and accrued liabilities | (1,841) |  | (415) |  | (58) |
| 90,928 |  | (339) |  | 618 |
Foreign currency rate | 1.4376 | 1.8571 | 1.5540 |
Equivalent in Canadian dollars | 130,718 |  | (630) |  | 960 |
Impact of 10% change in exchange rate | 13,072 |  | (63) |  | 96 |
Such analysis excludes any indirect economic or geo-political effects of such currency fluctuations.

X
- Definition Financial Instruments [Abstract] + References No definition available. + Details
Name: | cybn_FinancialInstrumentsAbstract
Namespace Prefix: | cybn_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for financial instruments. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 7 -IssueDate 2024-01-01 -Section Scope -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2024-en-r&doctype=Standard&dita_xref=IFRS07_g3-5A_TI -URIDate 2024-03-27 + Details
Name: | ifrs-full_DisclosureOfFinancialInstrumentsExplanatory
Namespace Prefix: | ifrs-full_
Data Type: | dtr-2022:textBlockItemType
Balance Type: | na
Period Type: | duration